Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 4 Morbidity and mortality compared between C+ and C−

From: Early mortality in hip fracture patients admitted during first wave of the COVID-19 pandemic in Northern Italy: a multicentre study

Hospital quality measures

C+ (n = 53); CI95

C− (n = 424); CI95

p; OR (CI95)

Post-operative complications (tot)

34 (64%); 0.51–0.76

205 (48%); 0.44–0.53

0.026; 0.52 (0.29–0.95)

 Acute anaemia

16 (30%)

138 (33%)

 

Pneumonia

6 (11%)

7 (2%)

 

 Other respiratory complications

6 (11%)

8 (2%)

 

 Acute heart failure

3 (6%)

9 (2%)

 

 Urinary tract infection

2 (4%)

7 (2%)

 

 Acute kidney failure

1 (2%)

2 (1%)

 

 Sepsis

0

3 (1%)

 

 Pulmonary thromboembolism

0

2 (1%)

 

 Ictus cerebri

0

2 (1%)

 

 Other minor complications

0

27 (7%)

 

Mortality, n (%)

 Inpatient post-operative mortality

8/53 (15%); 0.08–0.27

7/424 (2%); 0.01–0.03

 < 0.0001; 0.09 (0.03–0.27)

 Outpatient mortality (30-day)

12/53 (23%); 0.13–0.36

20/424 (5%);0.03–0.07

0.008; 0.17 (0.08–0.37)

 Mortality (t < 48 h)

10/42 (24%); 0.13–0.39

15/306 (5%); 0.03–0.08

 < 0.0001; 0.16 (0.07–0.40)

  IF

7/10

9/15

 

  HA

3/10

6/15

 

  THA

0

0

 

 Mortality (t ≥ 48 h)

1/11 (9%); 0.02–0.38

5/118 (4%); 0.02–0.10

0.420; 0.44 (0.05–4.17)

  IF

0

4/5

 

  HA

1/11

1/5

 

  THA

0

0

 
  1. Statistically significant differences (p < 0.05) are expressed as bold italic data
  2. t < or ≥ 48 h: treatment time from admission. OR: odds ratio. C+: patients with COVID-19; C−: control group; see definitions in Materials and methods